We sought out Aetion as a potential first financing round investment and were compelled by the depth of the founding team, our opportunity to recruit a game-changing C-level team, and early validation of their real-world evidence AI analytics solutions delivering valuable patient-level insights to pharma, payers and providers focused on what health treatments work, for whom, at what cost and who should pay for them.
Healthcare analytics company that delivers real-world evidence for the manufacturers, purchasers, and regulators of medical treatments and technologies.
Bill Geary
Executive Partner